Neuland Laboratories is a leading, global active pharmaceutical ingredient (API) manufacturing and development organization that caters to the pharmaceutical and biotech industry’s chemistry needs.
years of experience
API manufacturing capacity
APIs across 10 therapeutic areas
countries where customers are located
Drug Master Files (DMFs) worldwide
active US DMFs
revenue from exports
Profit after Tax
given by ECOVADIS FY 2022
employees covered under leadership & development interventions
treated wastewater recycled
reduction in carbon usage
Dr. Davuluri Rama Mohan Rao Executive Chairman
The sharp focus on our strategic priorities contributed to our strong financial and operational performance for the year. We remain focussed on driving business transformation by delivering against this multi-year strategy.
Aligned with our commitment to customer-centricity, embedding new strengths across different facets of our business is an ongoing endeavour. As we build a better and stronger organization, it also positions us well to achieve new paradigms of growth.
Significant steps have been taken on our ESG journey to build a company that creates value for all and for many years to come. Being awarded the ‘Silver Rating’ by EcoVadis, the world’s most trusted business sustainability rating, is a testament to our efforts.
We have a strong commitment to creating a positive impact in the communities where we operate. Through our CSR initiatives in education, health, infrastructure development and environmental conservation, we strive to make a difference.